Hypertension

Patients who continue RAS therapy had a lower risk of kidney replacement therapy.

A retrospective analysis of more than 7k patients from the ACCORD trial suggests intensive blood pressure and intensive blood glucose control could reduce the risk of cardiovascular autonomic neuropathy in diabetics.

Novartis indicates they will address manufacturing issues cited by the FDA.

An analysis of more than 7k patients from Brazil suggests high blood pressure at any age and for any amount of time was linked to accelerated cognitive decline later in life.

Data from more than 37k patients in the UK Biobank study suggests hypertension in midlife was linked to an increased risk of white matter hyperintensities later in life.

2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.

About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.

The shortage of kidney donors begs a need to consider safe approaches to expand the donor pool.

In data presented at AAO, investigators examine the impact of anti-VEGF injections on ocular hypertension.

In data presented at AAO 2020, researchers discover new methods for detecting different underlying conditions.

Dr. Albert discusses how preventative care and access to health care are important in closing health discrepancies.

Dr. Albert discusses some ways to close the racial outcome gaps in cardiology.

This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.

A study published in an AHA journal describes recent trends, predictors, and outcomes of stroke in patients with hypertensive disorders of pregnancy.

Investigators found no benefit from the discontinuation of ACE inhibitors/ARBs in patients hospitalized with COVID-19 in a prospective, randomized, phase 4 trial.

The largest and most comprehensive look at blood pressure therapies and cardiovascular disease risk to date is providing an overview of the effects of antihypertensive therapy at varying levels of baseline blood pressure.

An analysis of more than 3 million Europeans receiving an antihypertensive medication indicates medications for high blood pressure were not linked to an increase in risk of depressive disorders.

Analysis of 2500 women indicates hypertensive disorders of pregnancy increased the risk of experiencing menopausal symptoms later in life.

Our latest case report from Dr. Brady Pregerson features a 72 y/o male with a history of hypertension and TIA. Check out the EKG and see if you can determine the diagnosis.

A new study details the age-specific associations between high blood pressure and CVD risk among patients with diabetes.

New data from a study in Taiwan is detailing the complex interaction between physical activity and limiting exposure to high pollution levels.

Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.

An analysis of more than 180k patients in Hong Kong indicated use of the antihypertensive medications was associated with 22% lower risk of developing colorectal cancer.

New analysis of the Jackson Heart Study found experiencing a greater amount of discrimination could increase risk of hypertension in African Americans.

A new analysis of more than 47 million person-years of data indicates women who delivered a baby preterm were at a greater risk of developing ischemic heart disease.